Troglitazone (CS-045): A new antidiabetic agent

被引：16

作者：

Kaneko, T

机构：

[1] Yamaguchi Rosai Hospital, Onoda

[2] Yamaguchi Rosai Hospital, Onoda City Yamaguchi Prefecture 756

来源：

HORMONE AND METABOLIC RESEARCH | 1997年 / 29卷 / 05期

关键词：

D O I：

10.1055/s-2007-979023

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：203 / 213

页数：11

共 81 条

[1]

AKANUMA Y, 1993, J CLIN THER MED S3, V9, P127

[2]

AKANUMA Y, 1993, J CLIN THER MED, V9, P19

[3]

AKANUMA Y, 1993, J CLIN THER MED, V9, P39

[4] ACTIONS OF THE NOVEL ANTIDIABETIC AGENT ENGLITAZONE IN RAT HEPATOCYTES [J].

BLACKMORE, PF ;

MCPHERSON, RK ;

STEVENSON, RW .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (12) :1583-1587

[5] Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat [J].

Braissant, O ;

Foufelle, F ;

Scotto, C ;

Dauca, M ;

Wahli, W .

ENDOCRINOLOGY, 1996, 137 (01) :354-366

[6] PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-GAMMA - ADIPOSE-PREDOMINANT EXPRESSION AND INDUCTION EARLY IN ADIPOCYTE DIFFERENTIATION [J].

CHAWLA, A ;

SCHWARZ, EJ ;

DIMACULANGAN, DD ;

LAZAR, MA .

ENDOCRINOLOGY, 1994, 135 (02) :798-800

[7] INVITRO STUDIES ON THE ACTION OF CS-045, A NEW ANTIDIABETIC AGENT [J].

CIARALDI, TP ;

GILMORE, A ;

OLEFSKY, JM ;

GOLDBERG, M ;

HEIDENREICH, KA .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (10) :1056-1062

[8]

CIARALDI TP, 1994, CLIN RES, V42, pA26

[9] REGULATION OF ADIPOCYTE DEVELOPMENT [J].

CORNELIUS, P ;

MACDOUGALD, OA ;

LANE, MD .

ANNUAL REVIEW OF NUTRITION, 1994, 14 :99-129

[10] INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].

DEFRONZO, RA ;

FERRANNINI, E .

DIABETES CARE, 1991, 14 (03) :173-194

← 1 2 3 4 5 6 7 8 9 →